Latest available resultsQuarter ended July 31, 202610-Q · September 3, 2026
Filed with the SECMedtronic plc
MDTHealthcare
Next reportNovember 16, 2026Analyst forecast 1.358 $/share
Revenue
$9.76B
▲ +13.7% vs prior year% YoY
Net income
$1.47B
▲ +41.3% vs prior year% YoY
EPS
1.14$
▲ +40.7% vs prior year% YoY
Net margin
15.1%
▲ +2.9 percentage points vs prior year pp YoY
Revenue▲ +13.7 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +41.3 %
EPS▲ +40.7 %
View financial tableQuarter ended July 31, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $9.76B | |
| Gross profit | $6.34B | 65.0 % |
| Operating income | $1.76B | 18.1 % |
| Net income | $1.47B | 15.1 % |
| R&D | — | never filed |
| EPS (diluted) | 1.14 $ | |
| Balance sheet | ||
| Assets | $93.31B | |
| Liabilities | $42.46B | |
| Equity | $50.85B | |
| Cash | $1.69B | |
| Capital | ||
| Shares outstanding | 1.28B | as of 2026-08-28 |
| Public float | — | |